vs
Donnelley Financial Solutions, Inc.（DFIN）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Donnelley Financial Solutions, Inc.的季度营收约是再鼎医药的1.4倍（$172.5M vs $127.1M），再鼎医药同比增速更快（17.1% vs 10.4%），Donnelley Financial Solutions, Inc.自由现金流更多（$47.9M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -7.9%）
唐nelley金融解决方案（DFIN）是一家总部位于美国伊利诺伊州芝加哥市的金融合规企业，面向资本市场与投资市场的各类企业，提供符合美国监管要求的软件即服务产品、软件赋能服务、印刷业务及合规相关服务，助力客户满足合规要求。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
DFIN vs ZLAB — 直观对比
营收规模更大
DFIN
是对方的1.4倍
$127.1M
营收增速更快
ZLAB
高出6.8%
10.4%
自由现金流更多
DFIN
多$74.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $172.5M | $127.1M |
| 净利润 | $6.2M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 8.3% | -54.6% |
| 净利率 | 3.6% | — |
| 营收同比 | 10.4% | 17.1% |
| 净利润同比 | -1.6% | — |
| 每股收益（稀释后） | $0.31 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DFINZLAB
| Q4 25 | $172.5M | $127.1M | ||
| Q3 25 | $175.3M | $115.4M | ||
| Q2 25 | $218.1M | $109.1M | ||
| Q1 25 | $201.1M | $105.7M | ||
| Q4 24 | $156.3M | $108.5M | ||
| Q3 24 | $179.5M | $101.8M | ||
| Q2 24 | $242.7M | $100.1M | ||
| Q1 24 | $203.4M | $87.1M |
净利润DFINZLAB
| Q4 25 | $6.2M | — | ||
| Q3 25 | $-40.9M | $-36.0M | ||
| Q2 25 | $36.1M | $-40.7M | ||
| Q1 25 | $31.0M | $-48.4M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $8.7M | $-41.7M | ||
| Q2 24 | $44.1M | $-80.3M | ||
| Q1 24 | $33.3M | $-53.5M |
毛利率DFINZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率DFINZLAB
| Q4 25 | 8.3% | -54.6% | ||
| Q3 25 | 16.1% | -42.3% | ||
| Q2 25 | 24.2% | -50.3% | ||
| Q1 25 | 22.8% | -53.3% | ||
| Q4 24 | 6.0% | -62.6% | ||
| Q3 24 | 10.1% | -66.6% | ||
| Q2 24 | 26.6% | -76.0% | ||
| Q1 24 | 21.9% | -80.7% |
净利率DFINZLAB
| Q4 25 | 3.6% | — | ||
| Q3 25 | -23.3% | -31.2% | ||
| Q2 25 | 16.6% | -37.3% | ||
| Q1 25 | 15.4% | -45.8% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 4.8% | -40.9% | ||
| Q2 24 | 18.2% | -80.2% | ||
| Q1 24 | 16.4% | -61.4% |
每股收益（稀释后）DFINZLAB
| Q4 25 | $0.31 | $-0.05 | ||
| Q3 25 | $-1.49 | $-0.03 | ||
| Q2 25 | $1.28 | $-0.04 | ||
| Q1 25 | $1.05 | $-0.04 | ||
| Q4 24 | $0.21 | $-0.09 | ||
| Q3 24 | $0.29 | $-0.04 | ||
| Q2 24 | $1.47 | $-0.08 | ||
| Q1 24 | $1.09 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.5M | $689.6M |
| 总债务越低越好 | $171.3M | — |
| 股东权益账面价值 | $379.2M | $715.5M |
| 总资产 | $800.4M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资DFINZLAB
| Q4 25 | $24.5M | $689.6M | ||
| Q3 25 | $22.7M | $717.2M | ||
| Q2 25 | $33.8M | $732.2M | ||
| Q1 25 | $16.2M | $757.3M | ||
| Q4 24 | $57.3M | $779.7M | ||
| Q3 24 | $33.6M | $616.1M | ||
| Q2 24 | $35.0M | $630.0M | ||
| Q1 24 | $43.7M | $650.8M |
总债务DFINZLAB
| Q4 25 | $171.3M | — | ||
| Q3 25 | $154.7M | — | ||
| Q2 25 | $190.1M | — | ||
| Q1 25 | $189.5M | — | ||
| Q4 24 | $124.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DFINZLAB
| Q4 25 | $379.2M | $715.5M | ||
| Q3 25 | $423.1M | $759.9M | ||
| Q2 25 | $432.1M | $791.7M | ||
| Q1 25 | $419.9M | $810.8M | ||
| Q4 24 | $436.1M | $840.9M | ||
| Q3 24 | $444.5M | $667.7M | ||
| Q2 24 | $441.5M | $704.2M | ||
| Q1 24 | $408.9M | $762.2M |
总资产DFINZLAB
| Q4 25 | $800.4M | $1.2B | ||
| Q3 25 | $816.3M | $1.2B | ||
| Q2 25 | $874.7M | $1.2B | ||
| Q1 25 | $852.8M | $1.2B | ||
| Q4 24 | $841.6M | $1.2B | ||
| Q3 24 | $843.6M | $985.3M | ||
| Q2 24 | $882.9M | $987.4M | ||
| Q1 24 | $867.8M | $988.4M |
负债/权益比DFINZLAB
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.8M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $47.9M | $-26.7M |
| 自由现金流率自由现金流/营收 | 27.8% | -21.0% |
| 资本支出强度资本支出/营收 | 6.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 9.65× | — |
| 过去12个月自由现金流最近4个季度 | $107.8M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流DFINZLAB
| Q4 25 | $59.8M | $-26.0M | ||
| Q3 25 | $74.4M | $-32.0M | ||
| Q2 25 | $68.4M | $-31.0M | ||
| Q1 25 | $-37.7M | $-61.7M | ||
| Q4 24 | $56.4M | $-55.8M | ||
| Q3 24 | $86.4M | $-26.8M | ||
| Q2 24 | $56.2M | $-42.2M | ||
| Q1 24 | $-27.9M | $-90.1M |
自由现金流DFINZLAB
| Q4 25 | $47.9M | $-26.7M | ||
| Q3 25 | $59.2M | $-35.0M | ||
| Q2 25 | $51.7M | $-33.9M | ||
| Q1 25 | $-51.0M | $-63.2M | ||
| Q4 24 | $41.3M | $-58.4M | ||
| Q3 24 | $67.3M | $-28.2M | ||
| Q2 24 | $36.8M | $-42.9M | ||
| Q1 24 | $-40.2M | $-91.1M |
自由现金流率DFINZLAB
| Q4 25 | 27.8% | -21.0% | ||
| Q3 25 | 33.8% | -30.4% | ||
| Q2 25 | 23.7% | -31.1% | ||
| Q1 25 | -25.4% | -59.9% | ||
| Q4 24 | 26.4% | -53.8% | ||
| Q3 24 | 37.5% | -27.7% | ||
| Q2 24 | 15.2% | -42.9% | ||
| Q1 24 | -19.8% | -104.5% |
资本支出强度DFINZLAB
| Q4 25 | 6.9% | 0.5% | ||
| Q3 25 | 8.7% | 2.6% | ||
| Q2 25 | 7.7% | 2.6% | ||
| Q1 25 | 6.6% | 1.5% | ||
| Q4 24 | 9.7% | 2.4% | ||
| Q3 24 | 10.6% | 1.3% | ||
| Q2 24 | 8.0% | 0.7% | ||
| Q1 24 | 6.0% | 1.1% |
现金转化率DFINZLAB
| Q4 25 | 9.65× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | -1.22× | — | ||
| Q4 24 | 8.95× | — | ||
| Q3 24 | 9.93× | — | ||
| Q2 24 | 1.27× | — | ||
| Q1 24 | -0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
